8 completed, 6 unknown, 5 recruiting, 2 not yet recruiting. 24 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 24 | Completed 8, Unknown 6, Recruiting 5, Not yet recruiting 2, Active not recruiting 1, Terminated 1, Withdrawn 1 |
Follow Myeloma: new trials by email Literature Review of Myeloma trials Research Report on Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of a Wearable Core Body Temperature Sensor Versus Standard Temperature Monitoring for Early Detection of Cytokine Release Syndrome in Patients Undergoing CAR T-Cell Therapy in an Outpatient Setting TempShield Continuous Temperature Monitoring, Standard of Care - Myeloma | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 105 | 2026-12-01 | 2026-11-02 |
| Evaluation of Skin Tests in Biotherapy Allergies Drug skin tests (investigating hypersensitivity to a biotherapy) - Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck, Melanoma Neoplasms | Not applicable | Recruiting | University Hospital, Angers | 70 | 2026-06-17 | 2026-06-18 |
| HEME Home Transfusion Program HEME-Hospice Program - Leukemia, Myeloma | Not applicable | Recruiting | Dana-Farber Cancer Institute | 700 | 2025-09-10 | 2026-10-28 |
| Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy Home Automated Telemanagement (HAT) Patient Unit - Lymphoma, Myeloma | Not applicable | Recruiting | University of Utah | 40 | 2025-09-01 | 2026-02-05 |
| A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties Music Therapy/MT, Therapist-Attention Music Education/TAME Control - Blood Cancer, Lymphoma | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2025-06-27 | 2026-05-26 |
| Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care LLS Program - Leukemia, Lymphoma | Not applicable | Recruiting | University of Miami | 400 | 2025-02-04 | 2026-10-16 |
| PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications PRIOR [Proactive Intensive Oral Review & Treatment] - Oncology, Periodontitis | Not applicable | Not yet recruiting | University of Leeds | 60 | 2024-07-01 | 2024-06-10 |
| Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT Mycobiome Supporting Diet - Autologous Transplant, Myeloma | Not applicable | Withdrawn | Case Comprehensive Cancer Center | 2024-04-01 | 2024-04-26 | |
| Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma Drug and medical device - Multiple Myeloma, Myeloma Multiple | Not applicable | Active not recruiting | Poitiers University Hospital | 74 | 2023-10-23 | 2026-04-30 |
| Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy Resistance Training, Aerobic Exercise, Optional Aerobic Exercise Procedure - Lymphoma, Leukemia | Not applicable | Completed | H. Lee Moffitt Cancer Center and Research Institute | 20 | 2023-02-21 | 2026-03-31 |
| Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma Supportive care interventions - Multiple Myeloma, Myeloma | Not applicable | Completed | UNC Lineberger Comprehensive Cancer Center | 16 | 2021-12-01 | 2025-02-28 |
| Removing Transfusion Dependence as a Barrier to Hospice Enrollment Transfusion support - Hematologic Malignancy, Myelodysplastic Syndromes | Not applicable | Completed | Adam Olszewski | 18 | 2021-07-09 | 2026-01-15 |
| Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT physical therapy consult, Cognitive Assessment, Cancer Aging Research Group (CARG) assessment - Stem Cell Transplant Complications, Myeloma | Not applicable | Completed | Case Comprehensive Cancer Center | 20 | 2021-05-01 | 2025-08-05 |
| Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²) Adapted Physical Activity - Myeloma, Lymphoma | Not applicable | Unknown | Weprom | 57 | 2020-11-20 | 2021-10-08 |
| Machine Learning in Myeloma Response Machine Learning (ML) - Myeloma | Not applicable | Unknown | Royal Marsden NHS Foundation Trust | 50 | 2018-07-04 | 2022-01-11 |
| Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors CAR-CD19 T cell, CAR-BCMA T cell, CAR-GPC3 T cell - B Cell Lymphoma, B Cell Leukemia | Not applicable | Unknown | Kang YU | 18 | 2017-12-29 | 2020-10-08 |
| Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation Inspiratory Muscle Training, Aerobic Training - Lymphoma, Myeloma | Not applicable | Unknown | Daniel Godoy Martinez | 50 | 2017-11-11 | 2017-12-18 |
| WB-EMS and Nutrition in Patients With Hematological Malignancies whole-body electromyostimulation - Hematologic Diseases, Cachexia; Cancer | Not applicable | Unknown | University of Erlangen-Nürnberg Medical School | 40 | 2017-11-01 | 2018-06-14 |
| Feasibility of Pre Transplant Exercise (Pre-habilitation) for Multiple Myeloma Patients Awaiting Autologous Stem Cell Transplantation Supervised Exercise Program - Myeloma | Not applicable | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 23 | 2016-09-01 | 2018-10-29 |
| African American Cancer Clinical Trial Decisions: Testing Tailored Messages EMR Tailoring, Survey Tailoring, Physician Involvement - Myeloma, Lymphoma | Not applicable | Completed | Virginia Commonwealth University | 90 | 2015-05-01 | 2020-04-01 |
Showing 20 of 24. Sign in to see all of them.
Neoplasms, Plasma Cell (24) · Lymphoma (11) · Leukemia (8) · Hematologic Neoplasms (5) · Multiple Myeloma (3) · Myelodysplastic Syndromes (3) · Carcinoma, Hepatocellular (2) · Cytokine Release Syndrome (2) · Hematologic Diseases (2) · Neoplasms (2) · Anemia, Aplastic (1) · Cachexia (1) · Carcinoma, Bronchogenic (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1)
Neoplasms by Histologic Type (24) · Neoplasms (22) · Hemic and Lymphatic Diseases (18) · Immune System Diseases (17) · Immunoproliferative Disorders (17) · Lymphoproliferative Disorders (16) · Hematologic Diseases (13) · Lymphatic Diseases (13) · Neoplasms by Site (7) · Pathological Conditions, Signs and Symptoms (5) · Blood Protein Disorders (4) · Bone Marrow Diseases (4) · Cardiovascular Diseases (4) · Paraproteinemias (4) · Digestive System Diseases (3)
Algorithms (1) · Blood Specimen Collection (1) · Convolutional Neural Networks (1) · Cryotherapy (1) · Cyclophosphamide (1) · Electronic Health Records (1) · Equipment and Supplies (1) · Exercise (1) · Lead (1) · Lenalidomide (1) · Machine Learning (1) · Medication Review (1) · Mental Status and Dementia Tests (1) · Nutrition Assessment (1) · Pharmaceutical Preparations (1)
Case Comprehensive Cancer Center (2) · Adam Olszewski (1) · Dana-Farber Cancer Institute (1) · Daniel Godoy Martinez (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Intergroupe Francophone du Myelome (1) · Kang YU (1) · M.D. Anderson Cancer Center (1) · Memorial Sloan Kettering Cancer Center (1) · Poitiers University Hospital (1) · Rennes University Hospital (1) · Royal Marsden NHS Foundation Trust (1) · Sahlgrenska University Hospital (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · UNC Lineberger Comprehensive Cancer Center (1)
United States (12) · France (5) · United Kingdom (3) · Brazil (1) · China (1) · Germany (1)
Andrea G Rockall, FRCR (1) · Brenda H Cooper, MD (1) · Christina Messiou, MD, FRCR (1) · Christopher E Jensen, MD (1) · Ciara Freeman, MD, PhD (1) · Cindy Varga, MD (1) · Daniel G Martinez, PhD (1) · Douglas Sborov, MD, MS (1) · Ehsan Malek, MD (1) · Frank Penedo, PhD (1) · Kang Yu, MD (1) · Katell LE DU, MD (1) · Kevin Liou, MD (1)
PMID 27986738, PMID 28835615, PMID 30718802, PMID 31807987, PMID 34563917, PMID 34935483, PMID 36173561, PMID 36198471
R37CA289639 (1)